Amarin Corp Plcuk (AMRN) Common Equity (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Common Equity of $449.4 million for Q1 2026, down 5.12% YoY from $473.7 million in Q1 2025, and down 2.15% sequentially from $459.3 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Common Equity (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Common Equity across 17 years of filings, most recently posting $449.4 million for Q1 2026.

  • In Q1 2026, Common Equity fell 5.12% year-over-year to $449.4 million; the TTM figure through Mar 2026 stood at $449.4 million (down 5.12% YoY), while the FY2025 annual figure was $459.3 million, down 5.53% from the prior year.
  • Common Equity declined to $449.4 million in Q1 2026, from $459.3 million in the prior quarter.
  • Over the last five years, Common Equity for AMRN reached as high as $641.1 million in Q1 2022 and fell as low as $449.4 million in Q1 2026.
  • The 5-year median for Common Equity is $551.9 million (2024), against an average of $534.4 million.
  • Annual changes were most pronounced in 2022 — Common Equity rose 1.02% — and 2025, when it retreated 15.76%.
  • A 5-year view of Common Equity shows it stood at $595.3 million in 2022, then declined by 7.26% to $552.1 million in 2023, then retreated by 11.94% to $486.2 million in 2024, then fell by 5.53% to $459.3 million in 2025, then fell by 2.15% to $449.4 million in 2026.
  • According to Business Quant data, Common Equity over the past three periods registered $449.4 million, $459.3 million, and $458.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 31.20 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 81.19 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -6.61 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 47.38 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 45.93 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 9.19 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 23.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 90.40 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 449.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 449.41 Mn
Dec 31, 2025 459.28 Mn
Sep 30, 2025 458.89 Mn
Jun 30, 2025 464.92 Mn
Mar 31, 2025 473.69 Mn
Dec 31, 2024 486.18 Mn
Sep 30, 2024 531.38 Mn
Jun 30, 2024 551.88 Mn
Mar 31, 2024 545.94 Mn
Dec 31, 2023 552.10 Mn
Sep 30, 2023 553.15 Mn
Jun 30, 2023 569.13 Mn
Mar 31, 2023 584.79 Mn
Dec 31, 2022 595.33 Mn
Sep 30, 2022 587.83 Mn
Jun 30, 2022 580.04 Mn
Mar 31, 2022 641.11 Mn
Dec 31, 2021 667.10 Mn
Sep 30, 2021 642.50 Mn
Jun 30, 2021 645.32 Mn